Cancer Genomics and Proteomics

Aims & Scope

Cancer Genomics & Proteomics (CGP) is an international peer-reviewed journal designed to publish rapidly high quality articles and reviews on the application of genomic and proteomic technology to basic, experimental and clinical cancer research.

In this site you may find information concerning the editorial board, editorial policy, issue contents, subscriptions, submission of manuscripts and advertising.

The first issue of CGP circulated in January 2004.

Cancer Genomics & Proteomics is a journal of the International Institute of Anticancer Research.

From January 2013 CGP is converted to an online-only open access journal.

Cancer Genomics & Proteomics supports (a) the aims and the research projects of the INTERNATIONAL INSTITUTE OF ANTICANCER RESEARCH and (b) the organization of the INTERNATIONAL CONFERENCES OF ANTICANCER RESEARCH.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	2.6
2024	2.60

SJR (SCImago Journal Rank)

Year	Value
2024	0.697

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	51

Journal Rank

Year	Value
2024	8150

Journal Citation Indicator

Year	Value
2024	506

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Circulating Tumor DNA in Biliary Tract Cancer: Current Evidence and Future Perspectives

  Citation: 88

  Authors: ALESSANDRO, ANGELA DALIA, SIMONA, GIOVANNI

• Diagnosis of Non-small Cell Lung Cancer for Early Stage Asymptomatic Patients

  Citation: 74

  Authors: CHERYLLE, CHRISTOPHER L., ROBERT, OSITA, ANDREW, THOMAS

• Anticancer Effects of Nutraceuticals in the Mediterranean Diet: An Epigenetic Diet Model

  Citation: 60

  Authors: ROSA, ANTONELLA, EUFEMIA, ANGELO

• The Activity of Immune Checkpoint Inhibition in KRAS Mutated Non-small Cell Lung Cancer: A Single Centre Experience

  Citation: 58

  Authors: JAVIER, ALEX, VERANE, ALFREDO

• Fusion of the Genes <i>WWTR1</i> and <i>FOSB</i> in Pseudomyogenic Hemangioendothelioma

  Citation: 46

  Authors: IOANNIS, INGVILD, LUDMILA, SVERRE

• Pre-operative Plasma miR-21-5p Is a Sensitive Biomarker and Independent Prognostic Factor in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical Resection

  Citation: 41

  Authors: PETR, NATALIA, JAN, IGOR, PETRA, MARKETA, ZDENEK, ONDREJ, VLADIMIR

• <i>MGMT</i> Gene Promoter Methylation Status – Assessment of Two Pyrosequencing Kits and Three Methylation-specific PCR Methods for their Predictive Capacity in Glioblastomas

  Citation: 39

  Authors: LENE E., PETTER, TOR Ã…GE, SVERRE, FRANCESCA, IOANNIS

• MicroRNAs as Potential Targets for Therapeutic Intervention With Metastasis of Non-small Cell Lung Cancer

  Citation: 36

  Authors: ULRICH H., FABIAN, ADAM

• Whole Transcriptomic Analysis of Apigenin on TNFα Immuno-activated MDA-MB-231 Breast Cancer Cells

  Citation: 32

  Authors: DAVID, ELIZABETH, KARAM F.A.

• Proteomic Analysis of Primary Colon Cancer and Synchronous Solitary Liver Metastasis

  Citation: 32

  Authors: EUN-KYUNG, MIN-JEONG, YUNJAE, WON-SUK, HO HEE

---